ArticleFrontiers in physiology2026
Single-cell transcriptomics reveals heterogeneous neutrophil populations and diagnostic biomarkers in atherosclerosis.
Article in Frontiers in physiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Identification of mitochondria-associated hub genes related to alcohol-associated liver fibrosis progression in aldehyde dehydrogenase 2 deficiency.Frontiers in physiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Atherosclerosis, a chronic inflammatory arterial disease, involves complex interactions among diverse immune cells. Although single-cell RNA sequencing (scRNA-seq) has revealed cellular heterogeneity within atherosclerotic lesions, the diversity of neutrophils and their crucial genes in atherogenesis remain elusive. Methods: We integrated scRNA-seq data from six human atherosclerotic samples, comprising 47,604 single cells.The Harmony algorithm was applied for dimensionality reduction and batch effect correction, resulting in the identification of 16 distinct cell subtypes. High-resolution weighted gene co-expression network (hdWGCNA) analysis was performed to construct a gene co-expression network specifically within the neutrophil subtype. Characteristic genes were selected using Lasso regression. Immune infiltration analysis, gene set enrichment analysis (GSEA), and gene set variation analysis (GSVA) were conducted to investigate the biological functions and potential regulatory mechanisms of the key genes. An atherosclerosis animal model was employed to validate the expression levels of the key genes in carotid artery tissues. In addition, transcriptional regulatory network analysis and correlation analysis between key genes and atherosclerosis-related regulatory genes were carried out. Drug prediction was performed using the Connectivity Map (CMap) database. Results: A total of 16 cell subtypes were identified following batch effect correction. Annotation results revealed a increased proportion of neutrophils in atherosclerotic arteries compared to healthy controls. WGCNA analysis of neutrophil subtypes unveiled four key genes: CSTB, CHST15, RNASE1 and ATP2B1, which were validated as promising candidate biomarkers in independent cohorts (AUC >0.85). Preliminary validation in the animal model showed that the expression levels of the four genes were elevated in diseased carotid artery tissues compared to normal controls. Immune infiltration analysis demonstrated significant correlations between the key genes and the infiltration levels of multiple immune cell types. GSEA and GSVA showed that these genes were primarily enriched in pathways associated with inflammatory response, ferroptosis, and atherosclerosis-related signaling pathways. Transcriptional regulation analysis predicted potential transcription factors, and correlation analysis revealed significant associations between the key genes and known atherosclerosis-related regulatory genes. CMap analysis predicted several small-molecule compounds with potential therapeutic effects. Discussion: Our findings uncover the previously unrecognized heterogeneity of neutrophils in atherosclerosis and identify four key genes as promising diagnostic markers and therapeutic targets. These findings provide new insights into the pathogenesis of atherosclerosis and provide a theoretical basis for developing targeted therapies against this devastating disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.